Dr. Sudarshan Sharma, MD
Claim this profileSudarshan K Sharma MD Limited-Gynecologic Oncology
Studies Ovarian Cancer
Studies Ovarian Tumors
16 reported clinical trials
43 drugs studied
About Sudarshan Sharma, MD
Education:
- Graduated from Punjab State Medical Faculty, India, in 1972.
- Completed Residency in Obstetrics & Gynecology at Loyola University Medical Center (1977-1981).
- Undertook a Fellowship in Gynecologic Oncology at Loyola University Medical Center (1984-1986).
Experience:
- Board certified in Gynecologic Oncology and Obstetrics & Gynecology.
- Practicing since 1986, with a specialization in minimally invasive surgery using the da Vinci Robot.
Area of expertise
1Ovarian Cancer
BRCA1 positive
Stage IV
Stage III
2Ovarian Tumors
Stage IV
Stage III
Stage II
Affiliated Hospitals
Sudarshan K Sharma MD Limited-Gynecologic Oncology
Sudarshan K Sharma MD Limted-Gynecologic Oncology
Clinical Trials Sudarshan Sharma, MD is currently running
ONC-392 + Pembrolizumab
for Ovarian Cancer
This is a study to test the safety and efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian cancer patients.
Recruiting2 awards Phase 212 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Sudarshan Sharma, MD
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sudarshan Sharma, MD has experience with
- Quality-of-Life Assessment
- Questionnaire Administration
- Olaparib
- Cediranib Maleate
- Durvalumab
- Carboplatin
Breakdown of trials Sudarshan Sharma, MD has run
Ovarian Cancer
Ovarian Tumors
Serous Cystadenocarcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sudarshan Sharma, MD specialize in?
Sudarshan Sharma, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are Stage IV.
Is Sudarshan Sharma, MD currently recruiting for clinical trials?
Yes, Sudarshan Sharma, MD is currently recruiting for 5 clinical trials in Hinsdale Illinois. If you're interested in participating, you should apply.
Are there any treatments that Sudarshan Sharma, MD has studied deeply?
Yes, Sudarshan Sharma, MD has studied treatments such as Quality-of-Life Assessment, Questionnaire Administration, Olaparib.
What is the best way to schedule an appointment with Sudarshan Sharma, MD?
Apply for one of the trials that Sudarshan Sharma, MD is conducting.
What is the office address of Sudarshan Sharma, MD?
The office of Sudarshan Sharma, MD is located at: Sudarshan K Sharma MD Limited-Gynecologic Oncology, Hinsdale, Illinois 60521 United States. This is the address for their practice at the Sudarshan K Sharma MD Limited-Gynecologic Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.